Press releases

Transaction to expand interventional oncology portfolio with drug-eluting microspheres and spherical embolics

Boston Scientific will participate in an upcoming medtech and diagnostics conference on Nov. 19, 2015. A live webcast and replay will be available.

Boston Scientific will participate in the healthcare conference on November 17, 2015. Learn how to watch the webcast or replay.

"Our excellent third quarter performance was driven by strong sales and differentiated adjusted operating margin expansion," said CEO Mike Mahoney

Investment continues alliance for percutaneous mitral valve replacement established in 2012

Up to $25,000 in prizes to be awarded to winners

Clinical and economic data to be presented at world's leading interventional cardiology meeting

New category of drug-eluting stent approved for U.S. patients

Boston Scientific will webcast its conference call with financial results and business highlights for Q3 ended Oct. 28, 2015. Learn how to tune in.

Provides minimally invasive alternative to an esophagectomy

MAJESTIC trial data support strong safety profile with low target lesion revascularization rate

System includes first directional lead with current steering and expanded programming flexibility

Boston Scientific will participate in the Morgan Stanley healthcare conference on Sept. 17, 2015. Learn how to watch the webcast or replay.

Boston Scientific will participate in the healthcare conference on Sept. 9, 2015. Learn how to watch the webcast or replay.

Updated labeling allows backwards-compatibility for MRI scans for the industry's longest-lasting ICD and CRT-D systems

U.S. launch underway for therapy designed to treat Peripheral Artery Disease

Men’s health and prostate health acquisition positions Boston Scientific as a urology leader

Strategic alliance to expand Boston Scientific portfolio of remote monitoring solutions

"Our strong performance in the second quarter reflects the consistent execution of our global teams," said Mike Mahoney, CEO of Boston Scientific.

First guidewire designed specifically for TAVI/R now sized for smaller ventricles

First Patients Enrolled in the FAST Feasibility Study

Chairman Pete Nicholas welcomes James as a business leader with “significant financial knowledge, HR management and organizational planning skills.”

Demonstrates growing clinical acceptance for novel, procedure-based treatment option for severe asthma

Boston Scientific will webcast its conference call with financial results and business highlights for Q2 ending June 15, 2015. Learn how to tune in.

Study to evaluate patients implanted with S-ICD for primary prevention of sudden cardiac death in the setting of severely reduced cardiac function